Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$46.84 - $59.75 $548,449 - $699,612
-11,709 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$48.09 - $57.79 $29,815 - $35,829
620 Added 5.59%
11,709 $664,000
Q4 2021

Feb 08, 2022

BUY
$47.19 - $62.68 $523,289 - $695,058
11,089 New
11,089 $582,000
Q3 2021

Nov 15, 2021

SELL
$56.91 - $67.81 $598,408 - $713,022
-10,515 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$64.02 - $71.72 $5,633 - $6,311
88 Added 0.84%
10,515 $712,000
Q1 2021

May 14, 2021

BUY
$53.26 - $68.08 $81,647 - $104,366
1,533 Added 17.24%
10,427 $684,000
Q4 2020

Feb 02, 2021

SELL
$43.41 - $56.51 $57,388 - $74,706
-1,322 Reduced 12.94%
8,894 $501,000
Q3 2020

Nov 05, 2020

SELL
$47.43 - $60.75 $898,229 - $1.15 Million
-18,938 Reduced 64.96%
10,216 $496,000
Q2 2020

Jul 22, 2020

SELL
$43.51 - $66.59 $1.53 Million - $2.34 Million
-35,196 Reduced 54.69%
29,154 $1.62 Million
Q1 2020

May 06, 2020

BUY
$32.82 - $81.13 $660,600 - $1.63 Million
20,128 Added 45.52%
64,350 $3.26 Million
Q4 2019

Feb 03, 2020

BUY
$60.96 - $77.7 $2.31 Million - $2.95 Million
37,911 Added 600.71%
44,222 $3.42 Million
Q3 2019

Nov 04, 2019

BUY
$55.78 - $68.08 $352,027 - $429,652
6,311 New
6,311 $400,000
Q4 2018

Feb 07, 2019

SELL
$47.64 - $71.26 $435,286 - $651,102
-9,137 Closed
0 $0
Q3 2018

Oct 25, 2018

SELL
$52.03 - $71.41 $383,461 - $526,291
-7,370 Reduced 44.65%
9,137 $649,000
Q2 2018

Aug 02, 2018

BUY
$48.15 - $56.68 $583,818 - $687,245
12,125 Added 276.7%
16,507 $860,000
Q1 2018

Apr 23, 2018

BUY
$46.03 - $61.28 $201,703 - $268,528
4,382 New
4,382 $229,000
Q4 2017

Feb 08, 2018

SELL
$50.58 - $60.79 $1.5 Million - $1.81 Million
-29,695 Closed
0 $0
Q3 2017

Oct 24, 2017

BUY
$53.54 - $68.0 $1.59 Million - $2.02 Million
29,695
29,695 $1.65 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.